Stock KIDS ORTHOPEDIATRICS CORP.
Add to a list
To use this feature you must be a member
Log inSign up

All News OrthoPediatrics Corp.

Equities

KIDS

US68752L1008

Real-time Estimate Cboe BZX
Other stock markets
 10:22:26 2024-06-10 am EDT 		5-day change 1st Jan Change
29.22 USD -3.13% Intraday chart for OrthoPediatrics Corp. -7.55% -9.20%
May. 07 Truist Securities Raises Price Target on OrthoPediatrics to $38 From $35, Maintains Hold Rating MT
May. 07 Transcript : OrthoPediatrics Corp., Q1 2024 Earnings Call, May 07, 2024

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
OrthoPediatrics Corp. to Participate in the Truist Securities MedTech Conference
GL
OrthoPediatrics : Management Change/Compensation - Form 8-K
PU
OrthoPediatrics Corp. Continued Leading Sponsorship at 2024 EPOSNA Annual Meeting
GL
Truist Securities Raises Price Target on OrthoPediatrics to $38 From $35, Maintains Hold Rating
MT
Transcript : OrthoPediatrics Corp., Q1 2024 Earnings Call, May 07, 2024
Earnings Flash (KIDS) ORTHOPEDIATRICS Reports Q1 Revenue $44.7M, vs. Street Est of $41.8M
MT
OrthoPediatrics: Q1 Earnings Snapshot
AQ
OrthoPediatrics Corp. Reports First Quarter 2024 Financial Results and Increases Full Year 2024 Revenue Guidance
GL
OrthoPediatrics Corp. Revises Revenue Guidance for the Full Year 2024
CI
OrthoPediatrics Corp. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
OrthoPediatrics Corp. Receives “Breakthrough Device” Designation from FDA for eLLi™ Growing Rod System for Pediatric Patients with Scoliosis
GL
OrthoPediatrics Corp. Receives Breakthrough Device? Designation from FDA for eLLi Growing Rod System for Pediatric Patients with Scoliosis
CI
OrthoPediatrics Corp. to Report First Quarter 2024 Financial Results on May 7, 2024
GL
OrthoPediatrics Corp. to Highlight its Pediatric Scoliosis Solutions at 8th Annual International Children’s Spine Symposium (ICSS)
GL
OrthoPediatrics Corp. to Participate in the 23rd Annual Needham Virtual Healthcare Conference
GL
OrthoPediatrics Corp. to Participate in the 23rd Annual Needham Virtual Healthcare Conference
AQ
Truist Securities Adjusts Price Target on OrthoPediatrics to $32 From $31, Maintains Hold Rating
MT
Transcript : OrthoPediatrics Corp., Q4 2023 Earnings Call, Mar 07, 2024
OrthoPediatrics: Q4 Earnings Snapshot
AQ
OrthoPediatrics Corp. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. KIDS Stock
  4. News OrthoPediatrics Corp.